Inventor · disambiguated record
Takanori Yokota
Also filed as: YOKOTA TAKANORI
20 granted patents·21 pending applications·22 citations·filing 2010–2025
91Inventor score
Files withUNIV NAT CORP TOKYO MEDICAL & DENTAL30NAT UNIV CORP TOKYO MED & DENT2RENA THERAPEUTICS INC2UNIV TOKYO2YOKOTA TAKANORI2
Top patents by PatentIndex Score
41 records- 0190US10337006B2Chimeric double-stranded nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2017·Granted Jul 2, 2019·7 cites·11 claims
- 0288US11433089B2Blood-brain barrier permeable heteroduplex nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2017·Granted Sep 6, 2022·3 cites·12 claims
- 0388US11034955B2Chimeric double-stranded nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Jun 15, 2021·2 cites·14 claims
- 0487US2024158790A1Chimeric double-stranded nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2023·Application pending·0 cites
- 0585US10329567B2Chimeric double-stranded nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2018·Granted Jun 25, 2019·3 cites·8 claims
- 0680US10844374B2Chimeric single-stranded antisense polynucleotides and double-stranded antisense agentUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2017·Granted Nov 24, 2020·1 cites·20 claims
- 0777US12344841B2Chimeric double-stranded nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2021·Granted Jul 1, 2025·0 cites·37 claims
- 0876US11028387B2Double-stranded agents for delivering therapeutic oligonucleotidesUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2014·Granted Jun 8, 2021·2 cites·7 claims
- 0973US9816089B2Chimeric double-stranded nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2014·Granted Nov 14, 2017·1 cites·11 claims
- 1073US8507458B2System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicronNAT UNIV CORP TOKYO MED & DENT·Filed 2012·Granted Aug 13, 2013·1 cites·5 claims
- 1169US11260134B2Double-stranded nucleic acid complex having overhangUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2017·Granted Mar 1, 2022·1 cites·12 claims
- 1269US2023024153A1Blood-brain barrier permeable heteroduplex nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 1369US2023295628A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2023·Application pending·0 cites
- 1467US9937263B2Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating sameUNIV TOKYO·Filed 2014·Granted Apr 10, 2018·1 cites·24 claims
- 1566US2023414765A1Polymer having halogen-containing segment and pharmaceutical composition using sameAGC INC·Filed 2023·Application pending·0 cites
- 1666US2022154185A1HETERO DOUBLE-STRANDED antimiRUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 1765US11597928B2Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Mar 7, 2023·0 cites·20 claims
- 1864US11851654B2Nucleic acid with reduced toxicityUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Dec 26, 2023·0 cites·15 claims
- 1964US2025339459A1Modified heteronucleic acid containing morpholino nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 2062US2025179486A1Heteronucleic acid including 2'-modified nucleosideUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 2162US2024240183A1Heteronucleic acid containing scpBNA or AmNAUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 2260US12305169B2BBB-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted May 20, 2025·0 cites·28 claims
- 2358US10912838B2Carrier for use in delivering drug, conjugate, composition comprising same, and method for administrating sameUNIV TOKYO·Filed 2018·Granted Feb 9, 2021·0 cites·24 claims
- 2455US2023174981A1Heteronucleic acid containing morpholino nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2021·Application pending·0 cites
- 2554US2022307019A1Double-stranded nucleic acid complex and use thereofUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 2654US2024117346A1Modified hetero nucleic acidsUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 2753US2022135972A1Optimal ps modification pattern for heteronucleic acidsUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 2853US2021317455A1Inhibitor of tdp-43 aggregationUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Application pending·0 cites
- 2953US2022370491A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 3053US2020115710A1HETERO DOUBLE-STRANDED antimiRUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2018·Application pending·0 cites
- 3152US2025333736A1Bbb-crossing lipid ligand of hetero nucleic acidUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2025·Application pending·0 cites
- 3250US2016108395A1Chimeric single-stranded antisense polynucleotides and double-stranded antisense agentNAT UNIV CORP TOKYO MED & DENT·Filed 2014·Application pending·0 cites
- 3349US2022175817A1Pharmaceutical Composition for Treating Muscle DiseaseUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 3447US11674141B2Ischemic-lesion-site-specific gene therapyUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Jun 13, 2023·0 cites·17 claims
- 3547US8329670B2System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicronYOKOTA TAKANORI·Filed 2010·Granted Dec 11, 2012·0 cites·16 claims
- 3646US2021290143A1Bioelectric current estimation method, bioelectric current estimation apparatus, biomagnetic measurement apparatus, and biomagnetic measurement systemWATANABE TAISHI·Filed 2021·Application pending·0 cites
- 3741US10190117B2Double-stranded antisense nucleic acid with exon-skipping effectUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2014·Granted Jan 29, 2019·0 cites·14 claims
- 3838US9731025B2Pharmaceutical composition for transcolonic absorptionYOKOTA TAKANORI·Filed 2011·Granted Aug 15, 2017·0 cites·8 claims
- 3935US11234995B2α-synuclein expression inhibitorUNIV OSAKA·Filed 2017·Granted Feb 1, 2022·0 cites·13 claims
- 4033US2018223280A1Nucleic acid complexRENA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4133US2018228830A1Nucleic acid complex having at least one bulge structureRENA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takanori Yokota files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →